Home/Cadenza Bio/John Katzenellenbogen, PhD

JK

John Katzenellenbogen, PhD

Scientific Founder

Therapeutic Areas

Neurology Women's Health Autoimmune Diseases

Cadenza Bio Pipeline

Drug	Indication	Phase
ERβ Modulator Program	Multiple Sclerosis	Preclinical

Leadership Team at Cadenza Bio

Carol Curtis, PhD

Chief Executive Officer, Founder

Elaine Hamm, PhD

Chief Operating Officer, Founder

David Martin, PharmD, MBA

Chief Development Officer

Jamie Boney-Montoya, PhD

Director of R&D

Seema Tiwari-Woodruff, PhD

Scientific Founder

View full Cadenza Bio profile